BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 14648857)

  • 1. Postradiotherapy surveillance practice for head and neck squamous cell carcinoma--too much for too little?
    Schwartz DL; Barker J; Chansky K; Yueh B; Raminfar L; Drago P; Cha C; Austin-Seymour M; Laramore GE; Hillel AD; Weymuller EA; Wallner KE
    Head Neck; 2003 Dec; 25(12):990-9. PubMed ID: 14648857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience.
    Yao M; Dornfeld KJ; Buatti JM; Skwarchuk M; Tan H; Nguyen T; Wacha J; Bayouth JE; Funk GF; Smith RB; Graham SM; Chang K; Hoffman HT
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):410-21. PubMed ID: 16168834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distant metastases in head-and-neck squamous cell carcinoma treated with intensity-modulated radiotherapy.
    Yao M; Lu M; Savvides PS; Rezaee R; Zender CA; Lavertu P; Buatti JM; Machtay M
    Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):684-9. PubMed ID: 22169673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns of recurrence after selective postoperative radiation therapy for patients with head and neck squamous cell carcinoma.
    Murakami N; Matsumoto F; Yoshimoto S; Ito Y; Mori T; Ueno T; Tuchida K; Kashihara T; Kobayashi K; Harada K; Kitaguchi M; Sekii S; Umezawa R; Takahashi K; Inaba K; Igaki H; Itami J
    BMC Cancer; 2016 Mar; 16():192. PubMed ID: 26951089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term follow-up after transoral laser microsurgery and adjuvant radiotherapy for advanced recurrent squamous cell carcinoma of the head and neck.
    Christiansen H; Hermann RM; Martin A; Florez R; Kahler E; Nitsche M; Hille A; Steiner W; Hess CF; Pradier O
    Int J Radiat Oncol Biol Phys; 2006 Jul; 65(4):1067-74. PubMed ID: 16750331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of anaemia in patients with head and neck cancer receiving adjuvant postoperative radiotherapy in the Grampian region.
    Macdonald G; Hurman DC
    Clin Oncol (R Coll Radiol); 2004 Feb; 16(1):63-70. PubMed ID: 14768758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postoperative (chemo) radiation in patients with squamous cell cancers of the head and neck - clinical results from the cohort of the clinical cooperation group "Personalized Radiotherapy in Head and Neck Cancer".
    Maihoefer C; Schüttrumpf L; Macht C; Pflugradt U; Hess J; Schneider L; Woischke C; Walch A; Baumeister P; Kirchner T; Zitzelsberger H; Belka C; Ganswindt U
    Radiat Oncol; 2018 Jul; 13(1):123. PubMed ID: 29970111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrences near base of skull after IMRT for head-and-neck cancer: implications for target delineation in high neck and for parotid gland sparing.
    Eisbruch A; Marsh LH; Dawson LA; Bradford CR; Teknos TN; Chepeha DB; Worden FP; Urba S; Lin A; Schipper MJ; Wolf GT
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):28-42. PubMed ID: 15093896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Real-life efficacy of volumetric modulated arc therapy in head and neck squamous cell carcinoma.
    Moncharmont C; Vallard A; Guy JB; Prades JM; Rancoule C; Magné N
    Eur Ann Otorhinolaryngol Head Neck Dis; 2017 May; 134(3):165-169. PubMed ID: 28034705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implementation of intensity-modulated radiotherapy for head and neck cancers in routine practice.
    Bednarek C; Nguyen TV; Puyraveau M; Bonnet É; Lescut N; Azélie C; Miny J; Mauvais O; Maurina T; Tochet F; Bosset JF; Thariat J; Sun XS
    Cancer Radiother; 2017 Feb; 21(1):21-27. PubMed ID: 28034680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Locoregional Control and Toxicity in Head and Neck Carcinoma Patients following Helical Tomotherapy-Delivered Intensity-Modulated Radiation Therapy Compared with 3D-CRT Data.
    Santa Cruz O; Tsoutsou P; Castella C; Khanfir K; Anchisi S; Bouayed S; Matzinger O; Ozsahin M
    Oncology; 2018; 95(2):61-68. PubMed ID: 29895020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radical radiotherapy in head and neck squamous cell carcinoma: an analysis of prognostic and therapeutic factors.
    Dinshaw KA; Agarwal JP; Ghosh-Laskar S; Gupta T; Shrivastava SK
    Clin Oncol (R Coll Radiol); 2006 Jun; 18(5):383-9. PubMed ID: 16817329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Planned neck dissection as an adjunct to the management of patients with advanced neck disease treated with definitive radiotherapy: for some or for all?
    Narayan K; Crane CH; Kleid S; Hughes PG; Peters LJ
    Head Neck; 1999 Oct; 21(7):606-13. PubMed ID: 10487947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Initial experience with oropharynx-targeted radiation therapy for metastatic squamous cell carcinoma of unknown primary of the head and neck.
    Mourad WF; Hu KS; Shasha D; Concert C; Ishihara D; Lin W; Shourbaji RA; Ryniak M; Gamez ME; Lukens JN; Li Z; Culliney BE; Khorsandi AS; Tran T; Jacobson A; Manolidis S; Schantz S; Urken M; Persky MS; Harrison LB
    Anticancer Res; 2014 Jan; 34(1):243-8. PubMed ID: 24403470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgery with postoperative radiotherapy for pN2 head and neck squamous cell carcinoma.
    Joo YH; Cho KJ; Park JO; Nam IC; Kim CS; Cho HJ; Kim MS
    Acta Otolaryngol; 2013 Oct; 133(10):1104-9. PubMed ID: 24032573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Planned postradiotherapy neck dissection: Rationale and clinical outcomes.
    Sewall GK; Palazzi-Churas KL; Richards GM; Hartig GK; Harari PM
    Laryngoscope; 2007 Jan; 117(1):121-8. PubMed ID: 17202940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is routine follow-up useful after combined-modality therapy for advanced head and neck cancer?
    Cooney TR; Poulsen MG
    Arch Otolaryngol Head Neck Surg; 1999 Apr; 125(4):379-82. PubMed ID: 10208674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cervical lymph node metastases from unknown primary tumours. Results from a national survey by the Danish Society for Head and Neck Oncology.
    Grau C; Johansen LV; Jakobsen J; Geertsen P; Andersen E; Jensen BB
    Radiother Oncol; 2000 May; 55(2):121-9. PubMed ID: 10799723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant Chemoradiation After Surgical Resection in Elderly Patients With High-Risk Squamous Cell Carcinoma of the Head and Neck: A National Cancer Database Analysis.
    Woody NM; Ward MC; Koyfman SA; Reddy CA; Geiger J; Joshi N; Burkey B; Scharpf J; Lamarre E; Prendes B; Adelstein DJ
    Int J Radiat Oncol Biol Phys; 2017 Jul; 98(4):784-792. PubMed ID: 28602410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intensive chemoradiotherapy as a primary treatment for organ preservation in patients with advanced cancer of the head and neck: efficacy, toxic effects, and limitations.
    Hanna E; Alexiou M; Morgan J; Badley J; Maddox AM; Penagaricano J; Fan CY; Breau R; Suen J
    Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):861-7. PubMed ID: 15262764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.